ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $106 | -99.9% | 2,644 | -18.4% | 0.01% | +25.0% |
Q3 2022 | $104,000 | -14.0% | 3,240 | -20.6% | 0.00% | 0.0% |
Q2 2022 | $121,000 | +6.1% | 4,081 | +0.3% | 0.00% | +33.3% |
Q1 2022 | $114,000 | -47.0% | 4,069 | -12.8% | 0.00% | -25.0% |
Q4 2021 | $215,000 | +40.5% | 4,668 | +0.3% | 0.00% | +33.3% |
Q3 2021 | $153,000 | -9.5% | 4,652 | -3.5% | 0.00% | 0.0% |
Q2 2021 | $169,000 | +2.4% | 4,822 | +5.7% | 0.00% | 0.0% |
Q1 2021 | $165,000 | – | 4,562 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |